相关实验视频
Updated: Jun 12, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.4K
植物衍生化合物大麻是一种治疗认知障碍的新兴策略:随机试验的综合性审查
Adriana Yndart Arias1,2, Kamila Vadell2, Arti Vashist2
1Department of Dietetics and Nutrition, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, United States.
Frontiers in pharmacology
|September 26, 2024
概括
大麻素 (CBD) 显示出治疗认知障碍和焦虑的前景,有效剂量从200-1500毫克口服或13.75毫克蒸发. 需要进一步的研究来确定CBD作为神经认知障碍的最终治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 大麻素研究 研究 大麻素研究
背景情况:
- 认知障碍带来了治疗挑战,需要穿越血脑屏障的药物.
- 堪纳比迪醇 (CBD) 是一种非令人陶醉的大麻化合物,被认为对焦虑,炎症和氧化应激有潜在的治疗作用.
- 对认知障碍逆转的最佳CBD参数 (剂量,配方,途径) 仍未得到充分研究.
研究的目的:
- 审查大麻二醇 (CBD) 补充剂对认知障碍的益处.
- 评估研究设计,配方和CBD随机临床试验对认知问题的结果.
- 评估CBD在治疗认知障碍方面的安全性和有效性.
主要方法:
- 进行了随机临床试验的系统文献审查.
- 搜索的数据库包括PUBMED和佛罗里达国际大学研究图书馆.
- 选择了14项随机试验,并对其设计/结果进行了比较.
主要成果:
- 大麻素 (CBD) 在16项试验中,在9项试验中显示出对焦虑和认知障碍的改善.
- 有效剂量包括口服2001500毫克或蒸发13.75毫克的CBD,具有良好的安全性.
- 结果的变化可能源于不同的试验设计,小样本大小和不受控制的混因素.
结论:
- 大麻素 (CBD) 是治疗神经认知障碍的一个有前途的候选药物.
- 需要进一步的研究来确定CBD在治疗认知障碍中的治疗作用.
- 对于像阿尔茨海默氏症这样的疾病,CBD的潜力值得未来的研究.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
107
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
107
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
167
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
167
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
204
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
204

